Vera Therapeutics 15min chart: Bollinger Bands expanding upward, KDJ golden cross

According to the 15-minute chart for Vera Therapeutics, the Bollinger Bands are currently expanding upward, and the KDJ indicator has triggered a Golden Cross at 14:00 on 07/08/2025. This indicates that the market trend is being driven by bullish sentiment, with the momentum of the stock price shifting towards the upside and suggesting potential further increases.

Wall Street continues to climb, with the S&P 500 hitting all-time highs, and insider buying activity is providing investors with clear signals to consider. Two stocks, Vera Therapeutics (VERA) and Marriott Vacations Worldwide (VAC), have caught the attention of insiders who are buying millions of dollars’ worth of shares, indicating potential upside.

Vera Therapeutics (VERA)

Vera Therapeutics is a clinical-stage biopharmaceutical company focused on developing new treatments for immunological conditions. The company's lead drug candidate, atacicept, is in late-stage clinical trials for IgA nephropathy and lupus nephritis. Vera recently achieved several milestones in its atacicept program, including completing enrollment in the pivotal Phase 3 ORIGIN trial and beginning enrollment in the ORIGIN EXTEND study. The company aims to submit a Biologics License Application (BLA) to the FDA during 4Q25, with hopes for an accelerated approval process.

Despite these advancements, VERA shares have declined 44% year-to-date. However, Patrick Enright, a member of Vera’s Board of Directors, recently purchased 250,000 shares, worth $5.89 million at current valuations. This purchase, combined with his existing stake, totals $148 million. Goldman Sachs analyst Paul Choi has praised Vera’s atacicept as a clinically differentiated asset with a derisked profile and sees the company as a potential merger target. Choi assigns an M&A rank of 1, with a theoretical M&A valuation of $65 per share, and sets a Buy rating with a $55 price target, implying a 133.5% one-year upside potential.

Marriott Vacations Worldwide (VAC)

Marriott Vacations Worldwide is a timeshare entity built on the Marriott name, offering vacation ownership and timeshare programs. The company operates several brands, including Marriott Vacation Club, Sheraton Vacation Club, and Westin Vacation Club, with a portfolio of over 120 resorts in 80 countries. The company reported $1.2 billion in revenue during 1Q25, with earnings per share of $1.66, beating forecasts.

Despite a 17.5% year-to-date decline, Christian Asmar, a Director of the company, recently purchased 750,000 shares, worth ~$54.2 million. Barclays analyst Brandt Montour has praised VAC’s favorable risk-reward profile, given the company’s de-risked top-line outlook and favorable delinquency trends. Montour rates the shares as Overweight (Buy) with an $88 price target, suggesting a 22% one-year upside potential.

Conclusion

The insider buying activity in Vera Therapeutics and Marriott Vacations Worldwide provides investors with strong signals to consider. The upward expansion of Bollinger Bands and the Golden Cross indicator on the 15-minute chart for Vera Therapeutics suggest a bullish trend, while Marriott Vacations Worldwide’s favorable risk-reward profile and insider buying activity indicate potential upside. Investors should conduct their own analysis before making any investment decisions.

References

[1] https://finance.yahoo.com/news/millions-insider-buying-point-2-120755148.html